共 326 条
- [1] Swedberg K(2010)Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 875-885
- [2] Komajda M(2009)The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 54 1747-1762
- [3] Bohm M(2014)Is heart rate important for patients with heart failure in atrial fibrillation? JACC Heart Fail 2 213-220
- [4] Borer JS(2015)Prognostic significance of resting heart rate and use of beta-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry Circ Heart Fail 8 871-879
- [5] Ford I(2015)Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis Eur J Heart Fail 17 1182-1191
- [6] Dubost-Brama A(2010)Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 1363-1373
- [7] Lerebours G(2015)Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program Eur Heart J 36 669-675
- [8] Tavazzi L(2015)Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction Am J Med 128 1102-1108 e1106
- [9] Triposkiadis F(2016)2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 18 891-975
- [10] Karayannis G(2017)Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure Clin Res Cardiol 106 711-721